Royal Society of Chemistry, Analyst, 4(144), p. 1034-1051, 2019
DOI: 10.1039/c8an01722k
Full text: Unavailable
Direct sampling mass spectrometry enables high-performance clinical analysis, such as imaging, drug monitoring and point-of-care testing.